Advice for people with diabetes and their families
Savefor later Page saved! You can go back to this later in your Diabetes and
# Diabetes UK responds to reports that a no-deal Brexit could disrupt UK
Last week Sir Michael Rawlins, Chair of the Medicines and Healthcare products
Regulatory Authority (MHRA), expressed concerns that a failure to secure a
trade deal ahead of Brexit in 2019 could have a significant impact on the
Follow our Brexit blog for all the latest updates.
> We have issued the following response from our Director of Policy, Campaigns
> “More than a million people with diabetes in the UK rely on insulin. It’s
> absolutely vital that clear systems are in place to ensure that those who
> rely on insulin and other medicines from abroad continue to have access to
> them, and that there is no disruption in supply either now or in the future.
> “Insulin isn’t an optional extra for people with diabetes who rely on it, so
> it’s incredibly important that those companies involved in its production
> and supply, and those involved in guaranteeing its entry into the UK, work
> “Many people with diabetes reliant on insulin are getting worried that they
> may not have access to supplies needed. The Brexit Health Alliance – which
> Diabetes UK, through our membership of the Richmond Group of Charities, is a
> member – has raised concerns about medicines supply, and the need for
> manufacturers, suppliers, the Department of Health, NHS England and those
> leading the negotiations to work together to give urgent clarification on
> what systems and safeguards are in place to ensure continued access to
Insulin in the UK comes from three main pharmaceutical manufacturers, Lilly,
Sanofi and Novo Nordisk. Currently, all analogue and synthetic human insulin
is imported from outside of the UK, and these are the most common forms of
insulin used by people with diabetes in the UK.
**Novo Nordisk** is the world’s largest producer of insulin. They have
production sites in the US, Brazil, Denmark, France, China, Russia, Algeria
**Lilly** produces insulin in the US, Puerto Rico, France and Italy. They have
packaging facilities for these products in France and China.
**Sanofi** has manufacturing sites in Germany, Russia, India, China and Saudi
Arabia. They do manufacture some drugs in the UK, but insulin is not produced
A fourth provider, **Wockhardt,** manufacture animal insulin and have a plant
in Wrexham. Very few people use animal insulin in the UK, and it would not
currently be possible for them to supply the whole UK market.
## Keep up to date with our Brexit blog
Follow our blog for all the latest updates on Brexit and insulin supplies.
Stay up to date with our Brexit blog
Someone is diagnosed with diabetes every two minutes. Your donation can change
Savefor later Page saved! You can go back to this later in your Diabetes and
* Opens a new window for Diabetes UK on facebook
* Opens a new window for Diabetes UK on Twitter
* Opens a new window for Diabetes UK on youtube
* Opens a new window for Diabetes UK on instagram
© The British Diabetic Association operating as Diabetes UK, a **** charity
registered in England and Wales (no. 215199) and in Scotland (no. SC039136). A
company limited by guarantee registered in England and Wales with
(no.00339181) and registered office at Wells Lawrence House, 126 Back Church
Brand Icons/Telephone check - FontAwesome   " " Header icons/tick icons/uk
